Democrats have made giving government the power to negotiate drug prices a central campaign theme for decades. With the power to make it happen, they may fall short yet again.
COVID-19:
A 30-year campaign to control drug prices faces yet another failure
By The New York Times
| October 21, 2021
Most Popular
#1
The signs patients have the delta variant are different than original COVID-19
Cough, fever, and shortness of breath are common COVID-19 symptoms. Sinus congestion, runny nose and sore throat are symptoms of becoming infected with the delta variant. Sneezing more than usual...
Read More #2
CMS Suspends Enforcement of Vaccine Mandate for Healthcare Workers
In a December 2 memo to state survey agencies, CMS told surveyors not to survey to the vaccination rule until further notice. ...
Read More #3
OSHA Extends Public Comment On COVID-19 Vaccine Rule
OSHA has extended the public comment period until January 19, 2022. ...
Read More #4
2021 Look Back: Chief Nurses Get Creative in Tackling Staffing Shortages
From predictive algorithms to revisiting past care models to virtual nursing, nurse leaders are digging in and finding solutions to the current staffing crisis. ...
Read More #5
CDC Announces New ICD-10-CM Codes for COVID-19-related Conditions
All six new codes will be effective January 1, 2021. ...
Read More